Anti-CD22 (clone IOCR29) SynExpress C-BF-I4-K CD8+ T Cells

CAT#: ITS-1124-CR497
Clone: IOCR29
Host: Mouse
Cell Source: Modified CD8+ T cells
Species Reactivity: Human
Connector Fragments: CMV-BFP-IL-4-KpnI
Carrier Type: HBV
Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IOCR29). We employs the HBV (CMV-BFP-IL-4-KpnI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD22
Clone
IOCR29
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
CMV
Effector Gene
IL-4
Insertion Sites
KpnI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
HBV
Transformation Accuracy
0.95
Cell Culture
Suspension Culture
Target
CD22
Alternative Names
CD22; SIGLEC-2; SIGLEC2; CD22 molecule
Gene ID
P16871(Human)
UniProt ID
933(Human)
Format
Lyophilized/Liquid
Shipping
All cell products are transported using dry ice, or specialized refrigerated containers to ensure that their temperature remains within an appropriate range. For cell products that are particularly sensitive to temperature, transportation must be carried out in liquid nitrogen tanks to ensure the quality and viability of the products.
Handling Advice
Handle cells in a sterile environment to prevent contamination. Use aseptic techniques when transferring to new media or containers. Follow biosafety regulations for disposing of cell waste.
Storage
Keep cell products in the designated temperature range (usually liquid nitrogen or -80°C) to maintain viability.
For Research Use Only | Not For Clinical Use
Online Inquiry